Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Moore

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|September 28, 2000
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study GroupL B Saltz, J V Cox, C Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials GroupC A Townsley, K Chi, D S Ernst, et al.
Heart (British Cardiac Society)|June 27, 2007
Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF TrialB M Glover, S J Walsh, C J McCann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerM L Rothenberg, M J Moore, M C Cripps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialH A Burris, M J Moore, J Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2023
Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized TrialH A Burris, M J Moore, J Andersen, et al.
British Journal of Cancer|December 17, 2013
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancerD J Jonker, C S Karapetis, C Harbison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyH von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyH von der Maase, S W Hansen, J T Roberts, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|September 28, 2000
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study GroupL B Saltz, J V Cox, C Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials GroupC A Townsley, K Chi, D S Ernst, et al.
Heart (British Cardiac Society)|June 27, 2007
Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF TrialB M Glover, S J Walsh, C J McCann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerM L Rothenberg, M J Moore, M C Cripps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialH A Burris, M J Moore, J Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2023
Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized TrialH A Burris, M J Moore, J Andersen, et al.
British Journal of Cancer|December 17, 2013
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancerD J Jonker, C S Karapetis, C Harbison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyH von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyH von der Maase, S W Hansen, J T Roberts, et al.
Pageof 24